Patents by Inventor Gilles Chappuis

Gilles Chappuis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
    Publication number: 20070009550
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Application
    Filed: September 15, 2006
    Publication date: January 11, 2007
    Inventors: Deborah Haines, Gordon Allan, John Ellis, Brian Meehan, Edward Clark, Lori Hassard, John Harding, Catherine Charreyre, Gilles Chappuis, Francis McNeilly, Li Wang, Lorne Babiuk, Andrew Potter, Philip Willson
  • Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
    Publication number: 20060292177
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Application
    Filed: July 12, 2006
    Publication date: December 28, 2006
    Inventors: Deborah Haines, Gordon Allan, John Ellis, Brian Meehan, Edward Clark, Lori Hassard, John Harding, Catherine Charreyre, Gilles Chappuis, Francis McNeilly, Li Wang, Lorne Babiuk, Andrew Potter, Philip Willson
  • Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
    Publication number: 20060286642
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Application
    Filed: July 12, 2006
    Publication date: December 21, 2006
    Inventors: Deborah Haines, Gordon Allan, John Ellis, Brian Meehan, Edward Clark, Lori Hassard, John Harding, Catherine Charreyre, Gilles Chappuis, Francis McNeilly, Li Wang, Lorne Babiuk, Andrew Potter, Philip Willson
  • Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
    Publication number: 20060002952
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Application
    Filed: September 1, 2005
    Publication date: January 5, 2006
    Inventors: Deborah Haines, Gordon Allan, John Ellis, Brian Meehan, Edward Clark, Lori Hassard, John Harding, Catherine Charreyre, Gilles Chappuis, Francis McNeilly, Li Wang, Lorne Babiuk, Andrew Potter, Philip Willson
  • Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
    Publication number: 20050058653
    Abstract: Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses.
    Type: Application
    Filed: February 17, 2004
    Publication date: March 17, 2005
    Inventors: John Ellis, Gordon Allan, Brian Meehan, Edward Clark, Deborah Haines, Lori Hassard, John Harding, Catherine Charreyre, Gilles Chappuis, George Krakowka, Jean-Christophe Audonnet, Francis McNeilly
  • Feline infectious peritonitis vaccine
    Patent number: 6080850
    Abstract: The invention comprises the nucleotide sequences comprising the FIPV S gene, or a fragment of this gene, which are modified in at least one of the antigenic regions A1 and A2 which are involved in enhancement, as well as the use of these sequences for the expression of modified proteins, and for the construction of recombinant viruses or expression plasmids, and the use of the recombinant viruses as vaccines against feline infectious peritonitis, the use of the expression plasmids as immunizing composition by direct injection of the said plasmids into cats, and the use of the modified proteins as vaccine.
    Type: Grant
    Filed: August 28, 1995
    Date of Patent: June 27, 2000
    Assignee: Rhone Merieux
    Inventors: Raphael Darteil, Wayne Corapi, Franqis Jean-Christophe Audonnet, Emile Gilles Chappuis